Yoo, J.W.; Jo, S.; Ahn, M.B.; Kim, S.; Lee, J.W.; Kim, M.; Cho, B.; Chung, N.-G.
Front-Line Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia: A Study on Efficacy and Safety. Cancers 2023, 15, 3862.
https://doi.org/10.3390/cancers15153862
AMA Style
Yoo JW, Jo S, Ahn MB, Kim S, Lee JW, Kim M, Cho B, Chung N-G.
Front-Line Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia: A Study on Efficacy and Safety. Cancers. 2023; 15(15):3862.
https://doi.org/10.3390/cancers15153862
Chicago/Turabian Style
Yoo, Jae Won, Suejung Jo, Moon Bae Ahn, Seongkoo Kim, Jae Wook Lee, Myungshin Kim, Bin Cho, and Nack-Gyun Chung.
2023. "Front-Line Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia: A Study on Efficacy and Safety" Cancers 15, no. 15: 3862.
https://doi.org/10.3390/cancers15153862
APA Style
Yoo, J. W., Jo, S., Ahn, M. B., Kim, S., Lee, J. W., Kim, M., Cho, B., & Chung, N.-G.
(2023). Front-Line Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia: A Study on Efficacy and Safety. Cancers, 15(15), 3862.
https://doi.org/10.3390/cancers15153862